Trial Profile
ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Hydrochlorothiazide (Primary) ; Telmisartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms ONEAST
- 17 Oct 2016 Status changed from recruiting to completed.
- 27 Jul 2007 New trial record.